Dipartimento SPeA
Sezione di Chimica Fisica
Via Ca Le Suore, 2
61029, Urbino (PU)
Tel. +39 (0)722 304276
biodendrimer18@uniurb.it
SCIENTIFIC PROGRAMME
Monday, June 4th
14.00 - 15.30 Registration
15.30 - 15.45 Welcome and Introduction by M. Francesca Ottaviani
Chairperson: Anne-Marie Caminade
15.45 - 16.30 Xiangyang Shi Plenary: Synthesis of dendrimer-pyridine-copper(II) complexes for radiotherapy-enhanced MR imaging and chemotherapy of breast cancer. Publishing in a special issue on dendrimers in Pharmaceutics
16.30 - 16.55 Ken Cham-Fai Leung Higher-generation type III-B rotaxane dendrimers for anti-cancer drug encapsulation and active release
16.55 - 17.20 Joao Rodrigues Novel nitrile based PAMAM dendrimers functionalized with the [Ru(η5-C5H5)(PPh3)2]+ moiety: synthesis and cytotoxicity studies
17.30 Welcome Cocktail
Tuesday, June 5th
Chairperson: Donald Tomalia
09.00 - 09.30 Barbara Klajnert-Maculewicz Plenary: Fluorescent dendrimers without fluorophores
09.30 - 10.15 Ling Peng Plenary: Self-assembling dendrimer nanotechnology for biomedical applications
10.15 - 10.40 Coffee Break/Poster Session
10.40 - 11.25 Anne-Marie Caminade Plenary: Fluorescent dendrimers for biological uses
11.25 - 11.50 Evgeny K. Apartsin Biocompatible hydrogels based on phosphorus dendrimers as carriers for therapeutic nucleic acids
11.50 - 14.00 Lunch
Chairperson: Ling Peng
14.00 - 14.45 Andrea Danani Plenary: Elucidating the role of surface chemistry on cationic phosphorus: dendrimer-siRNA complexation
14.45 - 15.10 Xiaoxuan Liu Stimulus-sensitive self-assembling amphiphilic dendrimers as siRNA delivery platform
15.10 - 15.35 Victoria Leiro Rodriguez Fully biodegradability of PEG-dendritic block copolymers towards an efficient siRNA delivery
15.35 - 16.00 Marleen Wilde Biophysical studies of PAMAM interactions with membrane models
16.00 - 16.25 Coffee Break/Poster Session
16.25 - 16.50 Gianvito Grasso Elucidating the protective role of maltose-terminated PPI dendrimers in the aggregation of amyloid beta peptide in presence of copper Ions
16.50 - 17.15 Cláudia S. Camacho The challenge of designing powerful platinum-based prodrugs based on PAMAM dendrimers as anticancer agents
17.15 - 17.40 Thissa N. Siriwardena Discovery of novel peptide dendrimer from chemical space
Wednesday, June 6th
Chairperson: Jorn Christensen
09.30 - 10.10 Javier F. De La Mata Plenary: Carbosilane metallodendrimers as antitumoral agents
10.10 - 10.35 Rafael Gomez Topology and amphiphilicity of carbosilane dendritic systems in biomedical applications
10.35 - 11.00 Coffee Break/Poster Session
11.00 - 11.25 Carla S. Alves Influence of generation size of dendrimer-entrapped gold nanoparticles on cell viability, transfection, and differentiation
11.25 - 11.50 Dina Maciel Exploring the Antiviral Behaviour of Anionic Poly(alkylidenamine) Dendrimers as Potential Agents Against HIV-1 Infection
11.50 - 14.00 Lunch
Chairperson: Barbara Klajnert-Maculewicz
14.00 - 14.25 Anna Janaszewska Conjugates of PAMAM dendrimer, anticancer drug and monoclonal antibody: the new approach of a well–known strategy
14.25 - 14.50 Chai-Lin Kao Preparation and applications of boronic acid-functionalized PAMAM dendrimers
14.50 - 15.15 Dietmar Appelhans Non-covalent interactions for the fabrication of drug-delivery-systems and biohybrid associates
15.15 - 15.40 Riccardo Carloni Synthesis and characterization of differently functionalized Glycodendrimers to treat Alzheimer and Wilson’s disease
15.40 - 16.05 Dinh-Vu Nguyen Mastering active targeting, alleviating unspecific cellular uptake and tailoring in vivo fate of USPIOs through a dendritic coating
16.05 - 16.20 Coffee Break/Poster Session
16.20 - 16.55 Poster short presentations:
Dominika Wróbel,
Poster Prize

Interaction of glucose-modified carbosilane dendrimers with human serum albumin and liposomes;
17.00 - 19.00 Visit of Urbino: the Ducal Palace
20.00 Social Dinner
Thursday, June 7th
Chairperson: Andrea Danani
09.00 - 09.45 Donald A. Tomalia Plenary: The importance of systematic CNDP engineering: dendrimer based drug delivery from discovery to first FDA phase III clinical product approval (2017)
09.45 - 10.10 Rita F. Pires Polyurea Dendrimers in Inhalation Chemotherapy
10.10 - 10.35 Vasco D. B. Bonifácio Polyurea Dendrimers in Ovarian Cancer Therapeutics
10.35 - 10.50 Coffee Break
10.50 - 11.35 Jorn Christensen Plenary: Complexes of Indomethacin with 4-carbomethoxy-pyrrolidone PAMAM dendrimers show improved anti-inflammatory properties and temperature dependent binding and release profile
11.35 - 11.50 Final remarks of the Symposium and Presentation of Biodendrimer 2020
11.50 - 14.00 Lunch
Instructions to Speakers
Accepted formats of files are Microsoft® PowerPoint® (ppt or pptx), or Adobe® Acrobat® (pdf).
Instructions to Poster Presenters
Suggested poster size: 80 x 120 cm (width x height)